IN8bio Statistics
NASDAQ: INABHealthcareBiotechnologyUSD
1.38-0.02 (-1.43%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 1.12 -18.84%
IN8bio by the numbers
IN8bio has a market capitalization of $13.6 million based on 9.86M shares outstanding. With trailing EPS of $-1.62, IN8bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 20.8% above its 50-day average and 10.6% below its 200-day average.
Average daily trading volume is 58.36K shares, or about $80,542 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
INAB valuation vs. peer median
| Metric | INAB | Peer median | Difference |
|---|---|---|---|
| Market cap | $13.60M | $13.53M | +1% |
| Avg. volume | 58.36K | 290.99K | -80% |
Peer median across 8 companies: KPTI, CNSY, NIKI, CTXR, HIND, CLRB, TVRD, TPST.
Valuation
- Market cap
- $13.60M
- EPS (TTM)
- $-1.62
- Shares outstanding
- 9.86M
Price and trading
- Previous close
- 1.40
- Open
- 1.40
- Day range
- 1.33 – 1.40
- 52-week range
- 0.88 – 2.73
- 52-week change
- -42.74%
- Beta
- —
- Volume
- 20.92K
- Average volume
- 58.36K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 13.60M
- Forward Pe
- -1.45
- Eps
- -1.62
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.73
- Week52 Low
- 0.88
- Avg Volume
- 58,364.00
- Shares Outstanding
- 9.86M
- Ma50
- 1.14
- Ma200
- 1.54
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -49.45%
- Pct From52w Low
- 56.82%